|
CN111393499A
|
|
Method for removing triterpenoid impurities in diammonium glycyrrhizinate bulk drug
|
|
CN111393327A
|
|
Preparation method of valsartan intermediate
|
|
CN111153807A
|
|
Preparation method of N, N-dimethylamino chloropropane hydrochloride
|
|
CN111170950A
|
|
Method for preparing rosuvastatin calcium salt
|
|
CN106748928A
|
|
A kind of preparation method of Simvastatin side chain
|
|
CN106588689A
|
|
Method for recycling atorvastatin intermediate M4 from crystallization mother liquor waste liquor
|
|
CN106748856A
|
|
A kind of preparation method of methenamine hippu intermediate
|
|
CN106745112A
|
|
The preparation method of Magnesium dichloride hexahydrate is reclaimed in a kind of waste residue hydrolyzate from grignard
|
|
CN105906657A
|
|
Preparation method for anti-avian influenza drug reducer triethyl silicane
|
|
CN106008311A
|
|
Refinement method of indole-2-carboxylic acid
|
|
CN106008251A
|
|
Preparation method of 2-benzylidene isobutyryl acetanilide
|
|
CN106018598A
|
|
Method for measuring content of byproducts in difenidol hydrochloride intermediate N-(3-chloropropyl) piperidine
|
|
CN106008396A
|
|
Impurity in difenidol hydrochloride intermediate N-(3-chloropropyl) piperidine and preparation method of impurity
|
|
CN104447487A
|
|
Preparation method of atorvastatin semi-calcium
|
|
CN104402877A
|
|
Preparation method of atropine sulphate
|
|
CN104402921A
|
|
Preparation method for tertiary butyl dimethyl chlorosilane industrialized production crystal
|
